Evaluation of host quality of life and immune function in breast cancer patients treated with adjuvant chemotherapy plus oral administration of Lentinula edodes mycelia extract
Nagashima Y, Maeda N, Yamamoto S, Yoshino S, Oka M
Published in OncoTargets and Therapy
Key Findings
Patients receiving the mycelia extract reported less chemotherapy-related fatigue and maintained natural killer cell activity better than controls.
Conclusions
Adjunct use may ease chemotherapy burden.
Limitations
Small randomised study; open label; single centre.
Supplements Studied
Patients receiving the mycelia extract reported less chemotherapy-related fatigue and maintained natural killer cell activity better than controls.
Outcomes Measured
Patients receiving the mycelia extract reported less chemotherapy-related fatigue and maintained natural killer cell activity better than controls.
Patients receiving the mycelia extract reported less chemotherapy-related fatigue and maintained natural killer cell activity better than controls.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.